Диссертация (1140107), страница 26
Текст из файла (страница 26)
– №. 2.– С. 561-574. doi:10.1007/s12035-012-8267-8269) Track N. S. Regulatory peptides of the gut and brain //Canadian Journal ofSurgery. – 1983. – Т. 26. – №. 3. – С. 211-3, 228.270) Turnbaugh P. J. et al. A core gut microbiome in obese and lean twins //nature. –2009. – Т. 457. – №. 7228. – С.
480. doi:10.1038/nature07540271) Turnbaugh P. J. et al. The human microbiome project //Nature. – 2007. – Т. 449. –№. 7164. – С. 804. doi:10.1038/nature06244272) Tyakht A. V. et al. Human gut microbiota community structures in urban and ruralpopulations in Russia //Nature communications. – 2013. – Т. 4. – С. 2469.doi:10.1038/ncomms3469273) Ulusoy A. et al. Caudo‐rostral brain spreading of α‐synuclein through vagalconnections //EMBO molecular medicine. – 2013. – Т. 5.
– №. 7. – С. 1119-1127.doi:10.1002/emmm.201302475274) Underly R. et al. Expression of Alzheimer-Type Neurofibrillary Epitopes inPrimary Rat Cortical Neurons Following Infection with Enterococcus faecalis//Frontiersinagingneuroscience.–2016.–Т.7.–С.259.doi:10.3389/fnagi.2015.00259.275) Unger M. M. et al. Postprandial ghrelin response is reduced in patients withParkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheralbiomarker for early Parkinson’s disease? //Journal of neurology.
– 2011. – Т. 258. – №.6. – С. 982-990. doi: 10.1007/s00415-010-5864-1276) Unger M. M. et al. Short chain fatty acids and gut microbiota differ betweenpatients with Parkinson's disease and age-matched controls //Parkinsonism & relateddisorders. – 2016. – Т. 32. – С. 66-72. doi: 10.1016/j.parkreldis.2016.08.019277) Ushakova G. et al. The effect of long-term lactobacilli (lactic acid bacteria) enteral154treatment on the central nervous system of growing rats //The Journal of nutritionalbiochemistry.–2009.–Т.20.–№.9.–С.677-684.doi:10.1016/j.jnutbio.2008.06.010.278) van Schaik W. The human gut resistome //Phil. Trans. R. Soc.
B. – 2015. – Т. 370.– №. 1670. – С. 20140087. doi: 10.1098/rstb.2014.0087279) Velázquez O. C., Lederer H. M., Rombeau J. L. Butyrate and the colonocyte//Dietary fiber in health and disease. – Springer, Boston, MA, 1997. – С. 123-134.280) Villanueva R. Neurobiology of major depressive disorder //Neural plasticity. –2013. – Т. 2013. doi: 10.1155/2013/873278281) Visanji N.
P. et al. The prion hypothesis in Parkinson's disease: Braak to the future//Acta neuropathologica communications. – 2013. – Т. 1. – №. 1. – С. 2.doi:10.1186/2051-5960-1-2282) Vizcarra J. A., Wilson‐Perez H. E., Espay A. J. The power in numbers: gutmicrobiota in Parkinson's disease //Movement Disorders. – 2015. – Т. 30. – №. 3.
– С.296-298. doi:10.1002/mds.26116283) Vogt N. M. et al. Gut microbiome alterations in Alzheimer’s disease //Scientificreports. – 2017. – Т. 7. – №. 1. – С. 13537.284) Volkmann E. R. et al. Systemic sclerosis is associated with specific alterations ingastrointestinal microbiota in two independent cohorts //BMJ open gastroenterology. –2017. – Т. 4. – №.
1. – С. E000134. doi: 10.1136/bmjgast-2017-000134285) Wainwright M. et al. Microorganisms cultured from stratospheric air samplesobtained at 41 km //FEMS Microbiology Letters. – 2003. – Т. 218. – №. 1. – С. 161165. doi: 10.1111/j.1574-6968.2003.tb11513.x286) Wang J.
et al. Regional and global elevational patterns of microbial speciesrichness and evenness //Ecography. – 2017. – Т. 40. – №. 3. – С. 393-402. doi:10.1111/ecog.02216287) Wang Q. et al. Naive Bayesian classifier for rapid assignment of rRNA sequencesinto the new bacterial taxonomy //Applied and environmental microbiology. – 2007.
–Т. 73. – №. 16. – С. 5261-5267.288) Wang W. et al. Caspase-1 causes truncation and aggregation of the Parkinson’s155disease-associated protein α-synuclein //Proceedings of the National Academy ofSciences. – 2016. – Т. 113. – №. 34. – С. 9587-9592. doi:10.1073/pnas.1610099113.289) Wang Z.
et al. Skin microbiome promotes mast cell maturation by triggering stemcell factor production in keratinocytes //Journal of Allergy and Clinical Immunology. –2017. – Т. 139. – №. 4. – С. 1205-1216. e6. doi: 10.1016/j.jaci.2016.09.019.290) Whittaker R. H. Evolution and measurement of species diversity //Taxon. – 1972.– С.
213-251.291) Wickham H. ggplot2: elegant graphics for data analysis //J Stat Softw. – 2010. – Т.35. – №. 1. – С. 65-88.292) Wierzchos J. et al. Microbial colonization of Ca‐sulfate crusts in the hyperarid coreof the Atacama Desert: implications for the search for life on Mars //Geobiology. –2011. – Т. 9.
– №. 1. – С. 44-60. doi: 10.1111/j.1472-4669.2010.00254.x293) Willemze R. A. et al. Neural reflex pathways in intestinal inflammation:hypotheses to viable therapy //Nature Reviews Gastroenterology and Hepatology. –2015. – Т. 12. – №. 6. – С. 353. doi:10.1038/nrgastro.2015.56294) Wirdefeldt K. et al. Epidemiology and etiology of Parkinson’s disease: a review ofthe evidence //European journal of epidemiology. – 2011. – Т. 26. – №.
1. – С. 1.doi:10.1007/s10654-011-9581-6295) Woese C. R., Fox G. E. Phylogenetic structure of the prokaryotic domain: theprimary kingdoms //Proceedings of the National Academy of Sciences. – 1977. – Т. 74.– №. 11. – С. 5088-5090. doi:10.1073/pnas.74.11.5088296) Wong A. C.
N., Vanhove A. S., Watnick P. I. The interplay between intestinalbacteria and host metabolism in health and disease: lessons from Drosophilamelanogaster //Disease models & mechanisms. – 2016. – Т. 9. – №. 3. – С. 271-281.doi: 10.1242/dmm.023408297) Xie Y. et al.
Association of plasma homocysteine, vitamin B12 and folate levelswith cognitive function in Parkinson’s disease: A meta-analysis //Neuroscience letters. –2017. – Т. 636. – С. 190-195. doi: 10.1016/j.neulet.2016.11.007298) Yarygin K. et al. Abundance profiling of specific gene groups using precomputedgut metagenomes yields novel biological hypotheses //PloS one.
– 2017. – Т. 12. – №.1564. – С. E0176154. doi: 10.1371/journal.pone.0176154299) Yozgat Y. et al. Sphingomonas paucimobilis bacteraemia and shock in a patientwith rheumatic carditis //Indian journal of medical microbiology. – 2014. – Т. 32. – №.4. – С. 451. Doi: 10.4103/0255-0857.142253.300) Yu G. et al. Molecular characterization of the human stomach microbiota in gastriccancer patients //Frontiers in cellular and infection microbiology.
– 2017. – Т. 7. – С.302. doi: 10.3389/fcimb.2017.00302301) Zhang X. et al. Deep Metaproteomics Approach for the Study of HumanMicrobiomes //Analytical chemistry. – 2017. – Т. 89. – №. 17. – С. 9407-9415. doi:10.1021/acs.analchem.7b02224.302) Zhu X. et al. Microbiota-gut-brain axis and the central nervous system//Oncotarget. – 2017. – Т. 8. – №. 32.
– С. 53829. doi: 10.18632/oncotarget.17754.303) Zis P. et al. Non‐motor symptoms burden in treated and untreated early Parkinson'sdisease patients: argument for non‐motor subtypes //European journal of neurology. –2015. – Т. 22. – №. 8. – С. 1145-1150. doi:10.1111/ene.12733.304) Zis P. et al. Peripheral neuropathy in idiopathic Parkinson's disease: A systematicreview //Journal of the neurological sciences. – 2017. – Т.
378. – С. 204-209. doi:10.1016/j.jns.2017.05.023.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
